U.S. PHARMACOPEIA

Search USP29  
Pentobarbital Sodium
C11H17N2NaO3 248.25

2,4,6(1H,3H,5H)-Pyrimidinetrione, 5-ethyl-5-(1-methylbutyl)-, monosodium salt.
Sodium 5-ethyl-5-(1-methylbutyl)barbiturate [57-33-0].
Change to read:
» Pentobarbital Sodium contains not less than 98.0 percent and not more than 102.0 percent of C11H17N2NaO3, calculated on the dried basis. Where the material is labeled as intended solely for veterinary use, Pentobarbital Sodium contains not less than 97.0 percent and not more than 102.0 percent of C11H17N2NaO3, calculated on the dried basis.USP29
Packaging and storage— Preserve in tight containers.
Completeness of solution— Mix 1.0 g with 10 mL of carbon dioxide-free water: after 1 minute, the solution is clear and free from undissolved solid.
Identification—
A: Ultraviolet Absorption 197U
Solution: 10 µg per mL.
Medium: dilute ammonium hydroxide (1 in 200).
B: The retention time of the major peak in the chromatogram of the Assay preparation corresponds to that in the chromatogram of the Standard preparation, as obtained in the Assay.
C: Ignite about 200 mg: the residue effervesces with acids, and meets the requirements of the tests for Sodium 191.
pH 791: between 9.8 and 11.0, in the solution prepared in the test for Completeness of solution.
Loss on drying 731 Dry it at 105 for 6 hours: it loses not more than 3.5% of its weight.
Heavy metals, Method II 231: 0.003%.
Related compounds—
Mobile phase— Prepare as directed in the Assay.
Standard solution— Dissolve an accurately weighed quantity of USP Pentobarbital RS in Mobile phase, and dilute quantitatively, and stepwise if necessary, with Mobile phase to obtain a solution having a known concentration of about 0.001 mg per mL.
Test solution— Transfer about 110 mg of Pentobarbital Sodium, accurately weighed, to a 100-mL volumetric flask, add about 80 mL of Mobile phase, and sonicate until dissolved. Dilute with Mobile phase to volume, and mix.
Chromatographic system (see Chromatography 621)— The liquid chromatograph is equipped with a 214-nm detector and a 4.6-mm × 25-cm column that contains 5-µm packing L1. The flow rate is about 1.0 mL per minute. Chromatograph the Standard solution, and record the peak responses as directed for Procedure: the capacity factor, k¢, is not less than 2.5; the column efficiency is not less than 15,000 theoretical plates; the tailing factor is not more than 1.5; and the relative standard deviation for replicate injections is not more than 15.0%.
Procedure— Separately inject equal volumes (about 10 µL) of the Standard solution and Test solution into the chromatograph, record the chromatograms, and measure the areas for the major peaks. Calculate the percentage of any impurity in the portion of Pentobarbital Sodium taken by the formula:
(248.25/226.27)(10,000/F)(C/W)(ri / rS)
in which 248.25 and 226.27 are the molecular weights of pentobarbital sodium and pentobarbital, respectively; F is the relative response factor of the impurity according to the table below; C is the concentration, in mg per mL, of USP Pentobarbital RS in the Standard solution; W is the weight, in mg, of Pentobarbital Sodium, on the dried basis, used to prepare the Test solution; ri is the peak area for any impurity in the Test solution; and rS is the peak area for pentobarbital in the Standard solution: the impurities meet the requirements given in the table below:
Compound
Name
Relative
Retention
Time
Relative
Response
Factor
Limit (%)
6-Imino-5-ethyl-
5-(1-methyl-
butyl)barbituric
acid
about 0.39 1.5 0.2
5-Ethyl-5-(1-ethyl-
propyl)barbituric
acid*
about 0.93 1.0 0.1
Pentobarbital 1.0
5-Ethyl-5-(1,3-
dimethylbutyl)
barbituric acid
about 1.5 0.9 0.3
Unknown
impurities
1.0 0.1
Total 0.5
*  Where the material is labeled as intended solely for veterinary use, the limit of 5-ethyl-5-(1-ethylpropyl) barbituric acid is 3.0%.
Organic volatile impurities, Method I 467: meets the requirements.
Residual solvents 467: meets the requirements.
(Official January 1, 2007)
Assay— [NOTE—Use the value for Loss on drying obtained at the same time as the preparation of the Test solution in the test for Related compounds and the Assay preparation in the Assay.]
Mobile phase, Standard preparation, and Chromatographic system— Proceed as described in the Assay under Pentobarbital.
Assay preparation— Transfer about 110 mg of Pentobarbital Sodium, accurately weighed, to a 100-mL volumetric flask, add about 80 mL of Mobile phase, and sonicate until dissolved. Dilute with Mobile phase to volume, and mix. Transfer 10.0 mL of this solution to a 100-mL volumetric flask. Dilute with Mobile phase to volume, and mix.
Procedure— Separately inject equal volumes (about 10 µL) of the Standard preparation and the Assay preparation into the chromatograph, record the chromatograms, and measure the responses for the major peaks. Calculate the quantity, in mg, of C11H17N2NaO3 in the portion of Pentobarbital Sodium taken by the formula:
(248.25/226.27)1000C(rU / rS)
in which 248.25 and 226.27 are the molecular weights of pentobarbital sodium and pentobarbital, respectively; C is the concentration, in mg per mL, of USP Pentobarbital RS in the Standard preparation; and rU and rS are the peak areas obtained from the Assay preparation and the Standard preparation, respectively.
Auxiliary Information— Staff Liaison : Ravi Ravichandran, Ph.D., Senior Scientist
Expert Committee : (MDPP05) Monograph Development-Psychiatrics and Psychoactives
USP29–NF24 Page 1678
Pharmacopeial Forum : Volume No. 31(1) Page 73
Phone Number : 1-301-816-8330